These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7444858)

  • 1. Inhibition of thrombin on surfaces coated with immobilized heparin and heparin-like polysaccharides: a crucial non-thrombogenic principle.
    Larsson R; Olsson P; Lindahl U
    Thromb Res; 1980 Jul 1-15; 19(1-2):43-54. PubMed ID: 7444858
    [No Abstract]   [Full Text] [Related]  

  • 2. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of relationship between enhanced bleeding induced by heparin and other sulfated polysaccharides and enhanced catalysis of thrombin inhibition.
    Buchanan MR; Ofosu FA; Fernandez F; Van Ryn J
    Semin Thromb Hemost; 1986 Oct; 12(4):324-7. PubMed ID: 3787270
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin prevents thrombin inhibition by alpha 2 macroglobulin.
    Fischer AM; Bros A; Rafowicz S; Josso F
    Thromb Res; 1980 May 1-15; 18(3-4):567-71. PubMed ID: 6158112
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombin inactivation on surfaces with covalently bonded heparin.
    Pasche B; Kodama K; Larm O; Olsson P; Swedenborg J
    Thromb Res; 1986 Dec; 44(6):739-48. PubMed ID: 3798418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of protease nexin-1 activity by polysaccharides.
    Richard B; Bouton MC; Loyau S; Lavigne D; Letourneur D; Jandrot-Perrus M; Arocas V
    Thromb Haemost; 2006 Feb; 95(2):229-35. PubMed ID: 16493483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thrombin by sulfated polysaccharides isolated from green algae.
    Hayakawa Y; Hayashi T; Lee J; Srisomporn P; Maeda M; Ozawa T; Sakuragawa N
    Biochim Biophys Acta; 2000 Nov; 1543(1):86-94. PubMed ID: 11087944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-directed inhibitors: pharmacology and clinical use.
    White CM
    Am Heart J; 2005 Jan; 149(1 Suppl):S54-60. PubMed ID: 15644794
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
    Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
    Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-surface interaction: effect of albumin coating or heparin complexing on thrombogenic surfaces.
    Chang TM
    Can J Physiol Pharmacol; 1974 Apr; 52(2):275-85. PubMed ID: 4838187
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin uptake and inhibition on endothelium and surfaces with a stable heparin coating: a comparative in vitro study.
    Arnander C; Dryjski M; Larsson R; Olsson P; Swedenborg J
    J Biomed Mater Res; 1986 Feb; 20(2):235-46. PubMed ID: 3957961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man.
    Ryde M; Eriksson H; Tangen O
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
    Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
    Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation.
    Ben-Hadj-Khalifa S; Hézard N; Almawi WY; Remy MG; Florent B; Mahjoub T; Nguyen P
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):369-73. PubMed ID: 21577096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.
    Yao SK; McNatt J; Anderson HV; Eidt J; Cui KX; Golino P; Glas-Greenwalt P; Maraganore J; Buja LM; Willerson JT
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H374-9. PubMed ID: 1539695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.